Granulomatous lymphocytic interstitial lung disease

Area of Science:

• Immunology
• Pulmonology
• Rheumatology

Background:

• The use of high-dose intravenous gamma globulin and antimicrobials is increasing.
• This rise is associated with a growing incidence of noninfectious common variable immunodeficiency-related disorders.
• Granulomatous-lymphocytic interstitial lung disease (GLILD) is a notable example of such a disorder.

Purpose of the Study:

• To provide a comprehensive overview of the diagnosis and management of GLILD.
• To highlight the importance of a multidisciplinary approach in diagnosing GLILD.
• To emphasize the need for further research and data collection on GLILD.

Main Methods:

• Review of current clinical understanding and diagnostic approaches for GLILD.
• Discussion of management strategies based on existing literature and clinical experience.
• Emphasis on the necessity of multidisciplinary care models.

Main Results:

• GLILD diagnosis requires thorough clinical evaluation.
• Multidisciplinary care models are essential for accurate GLILD diagnosis.
• Therapeutic trials for GLILD are becoming feasible due to recent advancements in understanding.

Conclusions:

• The incidence of GLILD is expected to increase.
• Accurate diagnosis and effective management are critical for patients with GLILD.
• Further data from registries and population-based studies are needed to understand GLILD trends and burden.